Company intelligence / Profile preview

Agilisium

United States

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Agilisium is a leading data innovation partner for life sciences, pharma, and medical device companies, enabling end-to-end digital and AI-driven transformation across drug discovery, clinical trials, commercial operations, and regulatory compliance. They are recognized by Everest Group and ISG as a top specialist in digital and analytics for mid-market life science enterprises, but do not themselves develop therapeutics or run clinical trials.

Industry: Drug Discovery Services

Partnerships

Life Sciences Ontario (LSO)Amazon Web Services (AWS)Various large pharma, biotech, and medtech companies (unnamed)

Beyond the preview

Go deeper on Agilisium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agilisium.

Explore the full profile